Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers

NCT03364985 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DWP16001
DRUG: Placebo
DRUG: Dapagliflozin

Sponsor

Daewoong Pharmaceutical Co. LTD.